Local Inventor Honored for Developing World s First Antihistamine
George Rieveschl, PhD, while a chemical engineering professor at the University of Cincinnati (UC), invented the drug Benadryl, the worlds first effective antihistamine.
Dr. Rieveschl will be recognized in conjunction with the 60th anniversary of Benadryl, commonly used to treat allergy symptoms such as hay fever, rashes and hives. The reception will be held from 5:30 to 7 p.m. at the Queen City Club,
Dr. Rieveschl found that his two-part compound, originally tested to improve muscle-relaxing medications, dramatically blocked histamine, a chemical released in the body that narrows air passages in the lungs and causes inflammation.
This surprising breakthrough led to Benadryl becoming the first FDA-approved prescription antihistamine in 1946. First produced by Parke, Davis and Company, the drug is now distributed over-the-counter by the Parke-Davis division of Pfizer, Inc.
A 1937 alumnus of UC, Dr. Rieveschl spent 26 years working in the chemical industry as both a scientist and a consultant before returning to UC in 1970. He currently is a professor emeritus of environmental engineering.
Jane Henney, MD, senior vice president and provost for health affairs at the UC Academic Health Center, and Karen Gould, PhD, dean of the
Invented by UC scientist George Rieverschl, PhD, Benadryl is the world's first effective antihistamine.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.